Table 4 Mortality was significantly lower in the thrombus aspiration group that had occurred in 2.7% of group (B), but in 11.8% of group (A). There was non-significant difference between the two groups as regard other complication (stroke, non-fatal MI, and target vessel revascularization)
Thrombus aspiration | Test value | P value | Sig. | ||
|---|---|---|---|---|---|
No | Yes | ||||
No. = 136 | No. = 73 | ||||
Peri-procedural arrhythmic complications | |||||
No | 130 (95.6%) | 68 (93.2%) | 3.766 | 0.43 | NS |
Bradyarrythmia | 1 (0.7%) | 0 (0.0%) | |||
V. Tachycardia | 4 (2.9%) | 4 (5.5%) | |||
Atrial fibrillation | 1 (0.7%) | 0 (0.0%) | |||
Arrest (hypoxic) | 0 (0.0%) | 1 (1.4%) | |||
Peri-procedural vascular complications | |||||
No | 129 (94.9%) | 69 (94.5%) | 0.011 | 0.91 | NS |
Yes | 7 (5.1%) | 4 (5.5%) | |||
Primary outcome (MACE) | |||||
No adverse effect | 120 (88.2%) | 71 (97.3%) | 4.916 | 0.02 | S |
Mortality | 16 (11.8%) | 2 (2.7%) | |||